Application of preoperative MRI lesion identification algorithm in pediatric and young adult focal cortical dysplasia-related epilepsy

•MELD algorithm has variable performance across novel pediatric/young adult datasets.•MELD algorithm has high sensitivity for FCDIIB.•MELD algorithm has high sensitivity for FCD Type II in neonatal/infantile patients.•MELD algorithm has clinical utility in simulated real world MRI-negative populatio...

Full description

Saved in:
Bibliographic Details
Published inSeizure (London, England) Vol. 122; pp. 64 - 70
Main Authors Hom, Kara L., Illapani, Venkata Sita Priyanka, Xie, Hua, Oluigbo, Chima, Vezina, L. Gilbert, Gaillard, William D., Gholipour, Taha, Cohen, Nathan T.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.11.2024
Subjects
Online AccessGet full text
ISSN1059-1311
1532-2688
1532-2688
DOI10.1016/j.seizure.2024.09.024

Cover

More Information
Summary:•MELD algorithm has variable performance across novel pediatric/young adult datasets.•MELD algorithm has high sensitivity for FCDIIB.•MELD algorithm has high sensitivity for FCD Type II in neonatal/infantile patients.•MELD algorithm has clinical utility in simulated real world MRI-negative population. The purpose of this study was to evaluate the performance and generalizability of an automated, interpretable surface-based MRI classifier for the detection of focal cortical dysplasia. This was a retrospective cohort incorporating MRIs from the epilepsy surgery (FCD and MRI-negative) and neuroimaging (healthy controls) databases at Children's National Hospital (CNH), and a publicly-available FCD Type II dataset from Bonn, Germany. Clinical characteristics and outcomes were abstracted from patient records and/or existing databases. Subjects were included if they had 3T epilepsy-protocol MRI. Manually-segmented FCD masks were compared to the automated masks generated by the Multi-centre Epilepsy Lesion Detection (MELD) FCD detection algorithm. Sensitivity/specificity were calculated. From CNH, 39 FCD pharmacoresistant epilepsy (PRE) patients, 19 healthy controls, and 19 MRI-negative patients were included. From Bonn, 85 FCD Type II were included, of which 68 passed preprocessing. MELD had varying performance (sensitivity) in these datasets: CNH FCD-PRE (54 %); Bonn (68 %); MRI-negative (44 %). In multivariate regression, FCD Type IIB pathology predicted higher chance of MELD automated lesion detection. All four patients who underwent resection/ablation of MELD-identified clusters achieved Engel I outcome. We validate the performance of MELD automated, interpretable FCD classifier in a diverse pediatric cohort with FCD-PRE. We also demonstrate the classifier has relatively good performance in an independent FCD Type II cohort with pediatric-onset epilepsy, as well as simulated real-world value in a pediatric population with MRI-negative PRE.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1059-1311
1532-2688
1532-2688
DOI:10.1016/j.seizure.2024.09.024